[go: up one dir, main page]

Moore et al., 1995 - Google Patents

Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease …

Moore et al., 1995

View PDF
Document ID
5860412385438180909
Author
Moore K
Raasch R
Brouwer K
Opheim K
Cheeseman S
Eyster E
Lemon S
Van der Horst C
Publication year
Publication venue
Antimicrobial agents and chemotherapy

External Links

Snippet

The pharmacokinetics of zidovudine (ZDV) are established in patients with various stages of human immunodeficiency virus (HIV) disease. This study was conducted to determine the pharmacokinetic parameters of ZDV in patients with asymptomatic HIV infection and liver …
Continue reading at journals.asm.org (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Similar Documents

Publication Publication Date Title
Moore et al. Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease (AIDS Clinical Trials Group protocol 062)
Douek et al. Evidence for increased T cell turnover and decreased thymic output in HIV infection
EP0738141B1 (en) Sucrose ester and n-docosanol formulations
Lilja et al. Grapefruit juice—simvastatin interaction: Effect on serum concentrations of simvastatin, simvastatin acid, and HMG‐CoA reductase inhibitors
Jacobson et al. Effect of foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS
Wilde et al. Zidovudine: an update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy
Buss et al. Saquinavir and ritonavir pharmacokinetics following combined ritonavir and saquinavir (soft gelatin capsules) administration
DE69624354T2 (en) PHARMACEUTICAL COMPOSITION CONTAINING AN INHIBITOR OF PROTEINASE AND A MONOGLYCERIDE
Roilides et al. Defective antifungal activity of monocyte-derived macrophages from human immunodeficiency virus-infected children against Aspergillus fumigatus
LeBel et al. Tissue penetration of ciprofloxacin after single and multiple doses
Shah et al. Pharmacokinetics of high-dose intravenous ciprofloxacin in young and elderly and in male and female subjects
Glardina et al. Efficacy, plasma concentrations and adverse effects of a new sustained release procainamide preparation
Barbaro et al. Evaluation of long-term efficacy of interferon alpha-2b and ribavirin in combination in naive patients with chronic hepatitis C: an Italian multicenter experience
Aoyama et al. Pharmacokinetics of recombinant human interleukin‐11 (rhIL‐11) in healthy male subjects
Ruiz-Moreno et al. Levamisole and interferon in children with chronic hepatitis B
Wong et al. A pharmacokinetic evaluation of HIV protease inhibitors, cyclic ureas, in rats and dogs
Creasey et al. Pharmacokinetics of captopril in elderly healthy male volunteers
Massarella et al. The effect of probenecid on the pharmacokinetics of zalcitabine in HIV-positive patients
Sartori et al. Assessment of interferon cardiotoxicity with quantitative radionuclide angiocardiography
Morse et al. Pharmacokinetics of orally administered zidovudine among patients with hemophilia and a symptomatic human immunodeficiency virus (HIV) infection
JP5170940B2 (en) Composition containing high purity amphotericin B
Esdaile et al. The immunological effects of concomitant highly active antiretroviral therapy and liposomal anthracycline treatment of HIV-1-associated Kaposi's sarcoma
Hewitt et al. Pharmacokinetics and pharmacodynamics of granulocyte-macrophage colony-stimulating factor and zidovudine in patients with AIDS and severe AIDS-related complex
Le Thi et al. Pharmacokinetics of a five-day oral dihydroartemisinin monotherapy regimen in patients with uncomplicated falciparum malaria
Sullivan et al. Lipid complexing decreases amphotericin B inflammatory activation of human neutrophils compared with that of a desoxycholate-suspended preparation of amphotericin B (Fungizone)